SCP
LLY icon

Sender Company & Partners’s Eli Lilly LLY Stock Holding History

Sender Company & Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.5M Buy
+14,700
New +$14.9M 8.22% 3
2025
Q4 		– Sell
-900
Closed -$687K – 303
2025
Q3 		$687K Buy
+900
New +$670K 0.08% 221

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sender Company & Partners's LLY Position: Q1 2026 in Review

Sender Company & Partners increased its Eli Lilly (LLY) stake by 51% in Q1 2026, buying an estimated $4.44M and bringing the position to 13,000 shares worth $12M. The position accounts for 7.27% of the portfolio, ranked #5.

Sender Company & Partners first reported a position in LLY in Q3 2022 and has held it in 7 quarters since. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Sender Company & Partners held 13,000 shares of Eli Lilly worth $12M as of Q1 2026.
  • Sender Company & Partners bought 4,378 Eli Lilly shares in Q1 2026, an estimated $4.44M.
  • Eli Lilly made up 7.27% of Sender Company & Partners's portfolio in Q1 2026, its #5 holding.
  • Sender Company & Partners first reported a position in Eli Lilly in Q3 2022 and has held it in 7 quarters since.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Sender Company & Partners's 13F filing for Q1 2026, filed 15 May 2026.